Egetis Therapeutics AB (EGTX.ST) Q4 2024 Earnings

8NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.32
-0.29
-0.27
-0.24

Details

Expected EPS
-0.3180198
Actual EPS
-0.30045136945
Surprise EPS
0.02
Surprise Percent
+5.52%

Description

Egetis Therapeutics AB (EGTX.ST) has reported earnings of -0.30045136945 per share for Q4 2024.

0 Comments

Share your thoughts